(1994). When Regulatory Requirements Conflict with Ethical Study Design: The Case of Oral Ondansetron. Cancer Investigation: Vol. 12, No. 6, pp. 654-656.
No takes yet. Share an insight, caveat, or question.
Maurie Markman (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: